The FDA review of Moderna's application for an emergency use authorization of its coronavirus vaccine in adolescents may not be completed before January, the company said.
Angela Weiss/AFP via Getty Images
hide caption
A syringe is filled with a dose of the Pfizer-BioNTech COVID-19 vaccine. While the vaccine has now been authorized for children between ages 5 and 11, it may take several weeks for shots to become widely available.
Patrick T. Fallon/AFP via Getty Images
hide caption
Ari Blank got a comforting hand-squeeze from his mom in May as he was vaccinated against COVID-19 in Bloomfield Hills, Mich. This week, the Food and Drug Administration authorized the use of Pfizer's vaccine in even younger kids — ages 5 to 11.
Jeff Kowalsky/AFP via Getty Images
hide caption
Young men play a game of rugby at sunset in Nuku'alofa, Tonga, on April 10, 2019. The island nation of Tonga has reported its first-ever case of COVID-19 on Oct. 29, 2021 after a traveler from New Zealand tested positive.
Mark Baker/AP
hide caption
Marge Loennig, 87, says her hometown of Baker City, Ore., has become divided during the COVID-19 pandemic, a far different time than during the polio crisis when she was younger.
Kirk Siegler/NPR
hide caption
Like many seniors, William Stork of Cedar Hill, Mo., lacks dental insurance and doesn't want to pay $1,000 for a tooth extraction he needs. Health advocates see President Biden's Build Back Better agenda as a once-in-a-generation opportunity to provide dental coverage to people like Stork who are on Medicare. An unlikely adversary: the American Dental Association.
Joe Martinez for Kaiser Health News
hide caption
The NAACP urges professional athletes to reconsider signing with teams in Texas in light of the state's voting and abortion laws.
Roger Steinman/AP
hide caption
This microscope image provided by the National Institute of Allergy and Infectious Diseases shows SARS-CoV-2 virus particles, which cause COVID-19. According to a study released in The Lancet Global Health, a cheap antidepressant known as fluvoxamine reduced the need for hospitalization among high-risk adults with COVID-19.
AP
hide caption